Cargando…
The effect of small-molecule inhibition of MAPKAPK2 on cell ageing phenotypes of fibroblasts from human Werner syndrome
Fibroblasts derived from the progeroid Werner syndrome (WS) show reduced replicative lifespan and a “stressed” morphology, both phenotypes being alleviated by using the p38 MAP kinase inhibitor SB203580. Because p38 is a major hub for the control of stress-signalling pathways we were interested in e...
Autores principales: | Davis, Terence, Rokicki, Michal J, Bagley, Mark C, Kipling, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562269/ https://www.ncbi.nlm.nih.gov/pubmed/23360642 http://dx.doi.org/10.1186/1752-153X-7-18 |
Ejemplares similares
-
Investigating the role of c-Jun N-terminal kinases in the proliferation of Werner syndrome fibroblasts using diaminopyridine inhibitors
por: Davis, Terence, et al.
Publicado: (2011) -
Evaluating the Role of p38 MAPK in the Accelerated Cell Senescence of Werner Syndrome Fibroblasts
por: Davis, Terence, et al.
Publicado: (2016) -
Small Molecule Inhibition of p38 MAP Kinase Extends the Replicative Life Span of Human ATR-Seckel Syndrome Fibroblasts
por: Tivey, Hannah S. E., et al.
Publicado: (2013) -
Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome
por: Bagley, Mark C., et al.
Publicado: (2010) -
Molecule Set Comparator (MSC): a CDK-based open rich‐client tool for molecule set similarity evaluations
por: Rajan, Kohulan, et al.
Publicado: (2021)